Search Results - "Frolova F., N."

Clinical course and approaches to therapy in kidney transplant recipients with the novel COVID-19 disease by O. N. Kotenko, L. Yu. Artyukhina, N. F. Frolova, E. S. Stolyarevich

“…The COVID-19 pandemic has had global consequences due to the wide spread of the infection in the world, lack of currently proven effective therapy, resistance…”
Get full text

Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19) by Misyurina, E. N., Baryakh, E. A., Frolova, N. F., Kotenko, O. N., Mutovina, Z. Yu, Andreev, S. S., Tolstykh, T. N., Yatskov, K. V., Karimova, E. A., Makeshova, A. B., Rukavitsyn, O. A., Misyurin, A. V., Polyakov, Yu. Yu, Mingalimov, M. A., Chudnova, T. S., Gagloeva, D. E., Ivanova, D. D., Koneva, A. I., Kochneva, O. L., Zotina, E. N., Grishina, E. Yu, Shimanovskaya, L. T., Yakimets, V. N., Zhelnova, E. I.

“…In December 2019, cases of severe respiratory infection were reported in Wuhan, China. The disease was caused by a new, previously undescribed coronavirus,…”
Get full text

POS-628 THE IMPACT OF OBESITY ON ADVERSE OUTCOME OF COVID-19 IN PATIENTS ON MAINTENANCE HEMODIALYSIS DUE TO DIABETIC KIDNEY DISEASE by Zeltyn-Abramov M., E., Belavina I., N., Frolova F., N., Poteshkina G., N., Klochkova N., N., Kondrashkina V., S., Sokolova V., N.

Get full text

Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease by Zeltyn-Abramov, E. M., Lysenko, M. A., Frolova, N. F., Markova, T. N., Belavina, N. I., Klochkova, N. N., Kondrashkina, S. V., Iskhakov, R. T., Ushakova, A. I.

“…BACKGROUND : Patients with Type 2 Diabetes (T2DM) and patients on maintenance hemodialysis (MHD) are at a high risk of adverse clinical course of COVID-19. To…”
Get full text

Arthritis as a clinical manifestation of antineutrophil cytoplasmic antibody-associated systemic vasculitis: diagnostic difficulties by Beketova, T. V., Sygyrta, V. S., Chichasova, N. V., Frolova, N. F., Stolyarevich, E. S., Kotenko, O. N.

“…The clinical picture of the symptomatic phase of antineutrophil cytoplasmic antibody-associated systemic vasculitis (ANCA-SV) can vary widely and be…”
Get full text

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION by Frolova, N. F., Artyukhina, L. Yu, Stolyarevich, E. S.

“…The paper describes a clinical case of recurrent microscopic polyangiitis diagnosed 10 years after kidney allotransplantation that was accompanied by the…”
Get full text

PROBLEMS IN THE DIAGNOSIS AND TREATMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS: IN THE FOCUS OF ANCA-NEGATIVE PAUCI-IMMUNE GLOMERULONEPHRITIS by Beketova, T. V., Frolova, N. F., Stolyarevich, E. S., Volkov, M. Yu, Kotenko, O. N., Aleksandrova, E. N.

“…One of the most common  causes of rapidly progressive glomerulonephritis (GN)  is the so-called pauci-immune crescentic GN that is characterized  by no…”
Get full text

A rare concurrence of polymyalgia rheumatica and AA-amyloidosis by Radenska-Lopovok, S G, Kotenko, O N, Frolova, N F, Zagrebneva, A I, Stolyarevich, E S, Volodina, E V, Chervinko, V I, Kryukov, E V, Zubkin, M L

“…Polymyalgia rheumatica (PMR) is a rare chronic inflammatory disease. It predominantly affects the elderly. The disease has a slow onset, pain and stiffness in…”
Get more information

THE ONSET OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS MASKING RHEUMATOID ARTHRITIS by Frolova, N. F., Korsakova, L. V., Stolyarevich, E. S., Nikonorova, N. O., Beketova, T. V.

“…The paper describes a case of microscopic polyangiitis (MPA), the first clinical manifestation of which has been joint damage characterized chiefly by…”
Get full text

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY by E. S. Stolyarevich, L. Y. Artjukhina, I. G. Kim, L. G. Kurenkova, N. D. Fedorova, A. V. Frolov, N. F. Frolova, N. A. Tomilina

“…Tасrolimus (Tac) has been used for rescuing of renal allografts from refractory rejection that occurred during treatment with conventional cyclosporine A (CsA)…”
Get full text

The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic by Avdeev, S N, Chulanov, V P, Alexeeva, E I, Aleshina, O A, Bereznikov, A V, Kotenko, O N, Lila, A M, Mutovina, Z Y, Parovichnikova, E N, Fomina, D S, Frolova, N F, Shevchenko, A O

“…On July 3, 2023, an interdisciplinary Council of Experts "The burden of COVID-19 in a heterogeneous population of immunocompromised patients - post-pandemic…”
Get full text

Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19 by Kruglova, Tatyana S., Fomina, Darya S., Poteshkina, Nataliуa G., Frolova, Nadija F., Beloglazova, Irina P., Mutovina, Zinaida Yu, Samsonova, Inna V., Kovalevskaja, Elena A., Zagrebneva, Alena I., Serdotetckova, Sofya A., Chernov, Anton A., Lysenko, Maryana A.

“…Aim. To determine the criteria for the optimal use of IL-6 receptor blockers in patients with COVID-19 community-acquired pneumonia based on predictors of…”
Get full text

COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic by Zubkin, Mikhail L., Frolova, Nadiya F., Kim, Irina G., Ushakova, Anzhela I., Usatiuk, Sergei S., Iskhakov, Rustam T., Diakova, Ekaterina N., Chervinko, Valeriy I., Volodina, Elizaveta V., Tomilina, Natalia A., Kryukov, Evgeniy V.

“…Background. Present concepts of the novel coronavirus infection prognosis in haemodialysis (HD) patients are rather controversial. There is little information…”
Get full text

COVID-19 in solid organ transplant recipients: initial report from national multicenter observational study «ROKKOR-recipient by S. V. Gautier, A. O. Shevchenko, O. M. Tsirulnikova, S. M. Khomyakov, O. N. Kotenko, V. E. Vinogradov, I. N. Abyzov, G. D. Avetisyan, A. Yu. Anisimov, L. Yu. Artyukhina, M. T. Bekov, V. A. Berdinsky, V. S. Bogdanov, A. Yu. Bykov, A. Yu. Vinokurov, A. Yu. Goncharova, D. P. Evdokimov, D. V. Ezersky, V. E. Zagainov, V. M. Zakharevich, K. N. Zelenin, E. S. Ivanova, A. A. Kartashev, N. G. Kvadratova, I. G. Kim, N. N. Koloskova, V. L. Korobka, I. R. Kurbanuglov, M. A. Lysenko, I. A. Miloserdov, Ya. G. Moisyuk, G. V. Nikolaev, I. V. Ostrovskaya, N. Yu. Petrova, A. V. Petryaev, A. V. Pinchuk, V. S. Platonov, V. N. Poptsov, Z. A. Porchkhidze, D. A. Saydulaev, A. D. Sapozhnikov, S. B. Semchenko, M. M. Skorobogatov, V. Yu. Tereshchenko, N. F. Frolova, D. V. Khalikova, T. A. Khalilulin

“…We herein present our initial report from «ROKKOR-recipient», a national multicenter observational study. The prevalence, risk factors, clinical manifestations…”
Get full text

RHEUTMATIC MYALGIA COMPLICATED BY AA-AMYLOIDOSIS by Zubkin, M L, Ovchinnikov, Yu V, Frolova, N F, Chervinko, V I, Zagrebneva, A I, Volodina, E V, Stolyarevich, E S, Chumikov, A A, Novozhenov, V G, Radenska-Lopovok, S G

“…Rheumatic myalgia is associated with intense inflammation and, unlike other diseases, is very rarely complicated by AA- amyloidosis. Only 12 such cases have…”
Get more information

Optical parameters of subarid aerosol by Gardashevskaya, L. V., Ivanov, V. P., Kosheleva, O. V., Sidorenko, V. I., Filippov, V. L., Frolova, N. F.

Get full text

Action of a pepsin inhibitor on an acid proteinase of the lower fungi by Stepanov, V. M., Lobareva, L. S., Frolova, N. F., Oreshenko, L. I.

Get full text